Valorum Biologics | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,488 results for “Valorum Biologics”

Trials

View all 2043 →

Multi-omics to Predict Responses to Biologics in IBD

1,050 participants · First posted Sep 15, 2022

A Clinical Study to Evaluate the Efficacy of Biologics in SpA

40 participants · First posted May 22, 2020

Enrolling By Invitation

A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis

150 participants · First posted Nov 13, 2024

Drugs

View all 570 →

QBSAU

QBECP

SIG001 (Signature Biologics)

Organizations

View all 143 →

Valorum Biologics, Inc.

United States

GENSIGHT BIOLOGICS

France

BlueWillow Biologics

South Korea

News

View all 2732 →

Valorum Biologics Secures Exclusive Rights to Commercialize Formycon's Eylea Biosimilar in North America

Lupin Partners with Valorum Biologics for US Launch of Cancer Biosimilar Armlupeg

Lupin Receives Marketing Approval for Pegfilgrastim Biosimilar in India

Page 1 of 549